NVST
Envista Holdings Corp
NYSE · Health Care
$29.10
+4.39 (+17.77%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 2.40B | 2.40B | 1.80B | 1.78B | 1.89B |
| Net Income | -1,068,096,282 | -961,094,434 | 278.06M | 313.22M | 281.21M |
| EPS | — | — | — | — | — |
| Profit Margin | -44.6% | -42.3% | 15.5% | 17.6% | 14.9% |
| Rev Growth | +0.0% | +0.0% | +11.8% | -4.0% | +14.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 770.54M | 770.54M | 1.01B | 1.04B | 1.26B |
| Total Equity | 1.62B | 1.62B | 3.94B | 3.92B | 3.66B |
| D/E Ratio | 0.48 | 0.48 | 0.26 | 0.27 | 0.34 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -951,041,256 | -903,308,531 | 496.39M | 483.80M | 550.76M |
| Free Cash Flow | — | — | 357.43M | 349.52M | 421.34M |